Target intelligence / Profile preview

Oral bacterial amino acid transporters and metabolic enzymes

Molecular classification
Transporter, Enzyme
01

Overview

Oral bacterial amino acid transporters and metabolic enzymes represent a diverse group of proteins that mediate the uptake and catabolism of amino acids within the oral microbiome. These systems play a critical role in maintaining oral health by regulating the pH of dental plaque; for instance, the Arginine Deiminase System (ADS) converts arginine into ammonia, which neutralizes organic acids produced by cariogenic bacteria like Streptococcus mutans (1.2.3, 1.2.4). Conversely, the metabolism of sulfur-containing amino acids by anaerobic pathogens leads to the production of volatile sulfur compounds (VSCs), which are primary contributors to halitosis and are associated with the progression of periodontitis (1.3.1, 1.3.5). Therapeutic strategies targeting these pathways include the use of prebiotic arginine to selectively favor alkali-producing commensal bacteria and the application of metal ions like zinc to inhibit enzymes involved in malodorous gas production (1.1.1, 1.2.3). Understanding these metabolic networks is essential for developing precision microbiome-modulating therapies that shift the oral environment from a disease-associated state to a health-associated one (1.2.5).

Other names
Oral microbial amino acid metabolism systemsBacterial amino acid permeases and catabolic enzymesArginine deiminase system (ADS)Agmatine deiminase system (AgDS)Sulfur-containing amino acid metabolic pathway
02

Mechanism of action

Modulation of the oral microbiome through the enhancement of alkali-producing pathways (e.g., Arginine Deiminase System) to neutralize plaque acids, or the inhibition of enzymes that catabolize sulfur-containing amino acids into volatile sulfur compounds.

03

Biological functions

Amino acid transportAmino acid catabolismpH regulationBiofilm modulationEnergy productionAmmonia production
04

Disease associations

Dental cariesPeriodontitisHalitosisOral dysbiosis
05

Safety considerations

Risk of oral microbiome dysbiosisPotential for systemic absorption of metabolic inhibitorsVariable efficacy due to individual microbiome diversity
06

Interacting drugs

Arginine

4 more in the full profile.

07

Biomarkers

Salivary ammonia levelsArginine deiminase activityPlaque pHVolatile sulfur compound (VSC) concentration

Beyond the preview

Go deeper on Oral bacterial amino acid transporters and metabolic enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oral bacterial amino acid transporters and metabolic enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call